Examples of publications in which the authors successfully used our mastermixes and kits in their work.
487 publications
The Effect of the Optogenetic Stimulation of Astrocytes on Neural Network Activity in an In Vitro Model of AlzheimerТs Disease (Int J Mol Sci. 2024)
The complete coding sequence of Influenza A/Unknown/Chelyabinsk/206/H7N4 (Microbiol Resour Announc. 2024)
Tbp and Hprt1 Are Appropriate Reference Genes for Splenic Neutrophils Isolated from Healthy or Tumor-Bearing Mice (Biomedicines. 2024)
Subinhibitory concentrations of meropenem stimulate membrane vesicle production and modulate immune response in Bacteroides fragilis infection (Curr Res Microb Sci. 2024)
Studying Pathogenetic Contribution of a Variant of Unknown Significance, p.M659I (c.1977G > A) in MYH7, to the Development of Hypertrophic Cardiomyopathy Using CRISPR/Cas9-Engineered Isogenic Induced Pluripotent Stem Cells (Int J Mol Sci. 2024)
Soloxolone para-methylanilide effectively suppresses aggressive phenotype of glioblastoma cells including TGF-?1-induced glial-mesenchymal transition in vitro and inhibits growth of U87 glioblastoma xenografts in mice (Front Pharmacol. 2024)
Soloxolone N-3-(Dimethylamino)propylamide Restores Drug Sensitivity of Tumor Cells with Multidrug-Resistant Phenotype via Inhibition of P-Glycoprotein Efflux Function (Molecules. 2024)
Smoking-Mediated miR-301a/IRF1 Axis Controlling Immunotherapy Response in Lung Squamous Cell Carcinoma Revealed by Bioinformatic Analysis (Cancers (Basel) 2024)
Search for biocontrol agents among endophytic lipopeptide-synthesizing bacteria Bacillus spp. to protect wheat plants against Greenbug aphid (Schizaphis graminum) (Vavilovskii Zhurnal Genet Selektsii. 2024)
Safety and Immunogenicity Study of a Bivalent Vaccine for Combined Prophylaxis of COVID-19 and Influenza in Non-Human Primates (Vaccines (Basel) 2024)